Heron Therapeutics, Inc.
NASDAQ:HRTX
1.28 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 127.044 | 107.672 | 86.346 | 88.638 | 145.968 | 77.474 | 30.767 | 1.279 | 0 | 0 | 0 | 0 | 0.646 | 1.301 | 1.261 | 0.369 | 0.412 | 0 | 5.391 | 5.404 | 4.848 | 5.815 | 4.387 | 3.366 | 20.4 | 20 | 18.3 | 18.7 | 16.1 | 15.9 | 19.9 | 7.3 | 2.8 | 2.4 | 2.8 | 2.5 | 1.7 |
| Cost of Revenue
| 65.105 | 54.874 | 46.021 | 36.189 | 61.619 | 27.512 | 4.588 | 0.035 | 0.734 | 54.833 | 30.916 | 14.075 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.445 | 0.44 | 0.613 | 6.4 | 5.7 | 6 | 9.4 | 9.8 | 9 | 11.6 | 3.8 | 1.1 | 1.2 | 0.7 | 0.6 | 0.4 |
| Gross Profit
| 61.939 | 52.798 | 40.325 | 52.449 | 84.349 | 49.962 | 26.179 | 1.244 | -0.734 | -54.833 | -30.916 | -14.075 | 0.646 | 1.301 | 1.261 | 0.369 | 0.412 | 0 | 5.391 | 5.404 | 4.848 | 5.37 | 3.947 | 2.753 | 14 | 14.3 | 12.3 | 9.3 | 6.3 | 6.9 | 8.3 | 3.5 | 1.7 | 1.2 | 2.1 | 1.9 | 1.3 |
| Gross Profit Ratio
| 0.488 | 0.49 | 0.467 | 0.592 | 0.578 | 0.645 | 0.851 | 0.973 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0.923 | 0.9 | 0.818 | 0.686 | 0.715 | 0.672 | 0.497 | 0.391 | 0.434 | 0.417 | 0.479 | 0.607 | 0.5 | 0.75 | 0.76 | 0.765 |
| Reseach & Development Expenses
| 55.897 | 107.506 | 130.821 | 174.533 | 167.382 | 140.032 | 138.582 | 103.125 | 61.183 | 54.833 | 32.78 | 15.045 | 8.207 | 7.264 | 7.796 | 19.507 | 19.364 | 15.236 | 10.299 | 11.495 | 8.66 | 6.699 | 7.348 | 3.713 | 4.3 | 4.4 | 3.7 | 3.5 | 4.1 | 6.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 49.014 | 37.437 | 40.153 | 42.226 | 37.897 | 29.263 | 25.554 | 21.366 | 35.742 | 19.728 | 21.677 | 8.786 | 3.501 | 3.971 | 3.707 | 4.307 | 4.681 | 3.628 | 3.565 | 3.225 | 2.8 | 3.495 | 3.302 | 3.463 | 6.5 | 6 | 7.4 | 11.4 | 9.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 67.643 | 82.513 | 87.179 | 63.853 | 89.764 | 64.604 | 56.601 | 47.668 | 17.347 | 8.708 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 116.657 | 119.95 | 127.332 | 106.079 | 127.661 | 93.867 | 82.155 | 69.034 | 35.742 | 19.728 | 21.677 | 8.786 | 3.501 | 3.971 | 3.707 | 4.307 | 4.681 | 3.628 | 3.565 | 3.225 | 2.8 | 3.495 | 3.302 | 3.463 | 6.5 | 6 | 7.4 | 11.4 | 9.6 | 8.5 | 17.5 | 8.8 | 4.9 | 5.1 | 6.7 | 6.9 | 4.5 |
| Other Expenses
| 0.56 | -7.366 | -2.855 | 0.885 | 5.945 | 5.097 | -0.038 | -2.228 | -0.666 | -1.806 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.117 | 0.5 | 1.4 | 1.2 | 1.4 | 1.2 | 1.1 | 1.2 | 1.1 | 0.8 | 0.8 | 0.7 | 0.9 | 0.9 |
| Operating Expenses
| 172.554 | 227.456 | 258.153 | 280.612 | 295.043 | 233.899 | 220.737 | 172.159 | 96.925 | 74.561 | 54.457 | 23.831 | 11.708 | 11.235 | 11.503 | 23.814 | 24.045 | 18.864 | 13.864 | 14.72 | 11.46 | 10.194 | 10.65 | 7.059 | 11.3 | 11.8 | 12.3 | 16.3 | 14.9 | 15.9 | 18.7 | 9.9 | 5.7 | 5.9 | 7.4 | 7.8 | 5.4 |
| Operating Income
| -110.615 | -174.658 | -217.828 | -228.163 | -210.694 | -183.937 | -194.558 | -170.915 | -96.925 | -74.561 | -54.457 | -23.831 | -11.062 | -9.934 | -10.242 | -23.445 | -23.633 | -18.864 | -8.473 | -9.316 | -6.612 | -4.824 | -6.703 | -4.307 | 2.7 | 2.5 | -0.3 | -7 | -8.6 | -9 | -10.4 | -6.4 | -4 | -4.7 | -5.3 | -5.9 | -4.1 |
| Operating Income Ratio
| -0.871 | -1.622 | -2.523 | -2.574 | -1.443 | -2.374 | -6.324 | -133.632 | 0 | 0 | 0 | 0 | -17.124 | -7.636 | -8.122 | -63.537 | -57.362 | 0 | -1.572 | -1.724 | -1.364 | -0.83 | -1.528 | -1.28 | 0.132 | 0.125 | -0.016 | -0.374 | -0.534 | -0.566 | -0.523 | -0.877 | -1.429 | -1.958 | -1.893 | -2.36 | -2.412 |
| Total Other Income Expenses Net
| 0.056 | -7.366 | -2.855 | 0.885 | 5.945 | 5.097 | -2.926 | -2.228 | -0.666 | -1.806 | -0.826 | -0.599 | -0.373 | 2.738 | 0.024 | 0.52 | 3.833 | 24.381 | 0.29 | 0.224 | 0.153 | 0.297 | 0.713 | 0.026 | 0 | 0.2 | 0.3 | 0.4 | -0.2 | -0.3 | 0.9 | 0.6 | 0 | 1 | 0.9 | 1.1 | 0.5 |
| Income Before Tax
| -110.559 | -182.024 | -220.683 | -227.278 | -204.749 | -178.84 | -197.484 | -173.143 | -97.591 | -76.367 | -55.283 | -24.43 | -11.435 | -7.196 | -10.15 | -23.125 | -19.8 | 5.517 | -8.47 | -9.294 | -6.459 | -4.756 | -6.617 | -4.281 | 0 | 2.7 | 0 | -8.1 | -8.8 | -9.3 | -9.5 | -5.8 | -4 | -3.7 | -4.4 | -4.8 | -3.6 |
| Income Before Tax Ratio
| -0.87 | -1.691 | -2.556 | -2.564 | -1.403 | -2.308 | -6.419 | -135.374 | 0 | 0 | 0 | 0 | -17.701 | -5.531 | -8.049 | -62.669 | -48.058 | 0 | -1.571 | -1.72 | -1.332 | -0.818 | -1.508 | -1.272 | 0 | 0.135 | 0 | -0.433 | -0.547 | -0.585 | -0.477 | -0.795 | -1.429 | -1.542 | -1.571 | -1.92 | -2.118 |
| Income Tax Expense
| 2.731 | -47.508 | -3.021 | -2.847 | 1.872 | 7.769 | 3.899 | -1.099 | -0.734 | -0.578 | -0.333 | -1.279 | 0.379 | -2.588 | -0.122 | -0.32 | 0.041 | 0.119 | -0.263 | -0.095 | -2.249 | -1.046 | -4.19 | -12.859 | 0.3 | 0.6 | 0.7 | 2.4 | 0.8 | 0.8 | -0.5 | -0.2 | 0.3 | -0.8 | -0.8 | -0.9 | -0.3 |
| Net Income
| -110.559 | -134.516 | -217.662 | -224.431 | -204.749 | -178.84 | -197.484 | -173.143 | -97.591 | -76.367 | -55.283 | -23.348 | -11.814 | -7.346 | -10.028 | -23.125 | -20.163 | 5.266 | -8.21 | -9.221 | -4.363 | -3.778 | -2.514 | 8.552 | 2.4 | 1.9 | -0.7 | -9.4 | -9.4 | -9.8 | -9.9 | -5.6 | -4.3 | -3.9 | -4.5 | -5 | -3.8 |
| Net Income Ratio
| -0.87 | -1.249 | -2.521 | -2.532 | -1.403 | -2.308 | -6.419 | -135.374 | 0 | 0 | 0 | 0 | -18.288 | -5.646 | -7.952 | -62.669 | -48.939 | 0 | -1.523 | -1.706 | -0.9 | -0.65 | -0.573 | 2.541 | 0.118 | 0.095 | -0.038 | -0.503 | -0.584 | -0.616 | -0.497 | -0.767 | -1.536 | -1.625 | -1.607 | -2 | -2.235 |
| EPS
| -0.8 | -1.24 | -2.21 | -2.47 | -2.5 | -2.44 | -3.65 | -4.57 | -2.95 | -2.87 | -3.42 | -1.91 | -1.96 | -3.7 | -6.15 | -15.01 | -20.83 | 66.7 | -26.15 | -32.2 | -16.98 | -14.81 | -9.92 | 33.6 | 9.6 | 10.4 | -2.88 | -40.96 | -45.69 | -48.87 | -58.03 | -34.5 | -34.4 | -32.14 | -37.86 | -43.99 | -35.08 |
| EPS Diluted
| -0.8 | -1.24 | -2.21 | -2.47 | -2.5 | -2.44 | -3.65 | -4.57 | -2.95 | -2.87 | -3.42 | -1.91 | -1.96 | -3.7 | -6.15 | -15.01 | -20.83 | 66.25 | -26.15 | -32.2 | -16.98 | -14.81 | -9.92 | 33.6 | 9.6 | 9.6 | -2.88 | -40.96 | -45.69 | -48.87 | -58.03 | -34.5 | -34.4 | -32.14 | -37.86 | -43.99 | -35.08 |
| EBITDA
| -103.792 | -176.661 | -215.252 | -222.53 | -201.233 | -174.655 | -192.016 | -169.38 | -96.191 | -73.983 | -54.457 | -23.831 | -10.883 | -6.967 | -9.862 | -22.513 | -19.441 | 5.911 | -8.027 | -9.024 | -5.959 | -4.582 | -6.769 | -4.034 | -1.5 | -2 | -0.8 | -7.1 | -7.4 | -7.9 | -9.2 | -5.3 | -3.2 | -3.9 | -4.6 | -5 | -3.2 |
| EBITDA Ratio
| -0.848 | -1.622 | -2.523 | -2.574 | -1.429 | -2.374 | -6.241 | -133.632 | 0 | 0 | 0 | 0 | -16.847 | -9.567 | -7.836 | -62.238 | -62.745 | 0 | -1.49 | -1.67 | -1.301 | -0.758 | -1.455 | -1.322 | 0.157 | 0.185 | 0.049 | -0.241 | -0.447 | -0.478 | -0.508 | -0.836 | -1.286 | -2.042 | -1.964 | -2.44 | -2.176 |